BSFAF
Price
$0.04
Change
-$0.02 (-33.33%)
Updated
May 14 closing price
Capitalization
3.33M
SOLTF
Price
$6.22
Change
+$0.02 (+0.32%)
Updated
Aug 5 closing price
Capitalization
574.74M
Interact to see
Advertisement

BSFAF vs SOLTF

Header iconBSFAF vs SOLTF Comparison
Open Charts BSFAF vs SOLTFBanner chart's image
BSF Enterprise
Price$0.04
Change-$0.02 (-33.33%)
Volume$10K
Capitalization3.33M
Nxera Pharma
Price$6.22
Change+$0.02 (+0.32%)
Volume$500
Capitalization574.74M
BSFAF vs SOLTF Comparison Chart in %
Loading...
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSFAF vs. SOLTF commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSFAF is a Buy and SOLTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (BSFAF: $0.04 vs. SOLTF: $6.22)
Brand notoriety: BSFAF and SOLTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BSFAF: 100% vs. SOLTF: 71%
Market capitalization -- BSFAF: $3.33M vs. SOLTF: $574.74M
BSFAF [@Biotechnology] is valued at $3.33M. SOLTF’s [@Biotechnology] market capitalization is $574.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSFAF’s FA Score shows that 0 FA rating(s) are green whileSOLTF’s FA Score has 0 green FA rating(s).

  • BSFAF’s FA Score: 0 green, 5 red.
  • SOLTF’s FA Score: 0 green, 5 red.
According to our system of comparison, BSFAF is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SOLTF’s TA Score shows that 5 TA indicator(s) are bullish.

  • SOLTF’s TA Score: 5 bullish, 4 bearish.

Price Growth

BSFAF (@Biotechnology) experienced а 0.00% price change this week, while SOLTF (@Biotechnology) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($575M) has a higher market cap than BSFAF($3.33M). SOLTF YTD gains are higher at: 1.015 vs. BSFAF (-12.500). BSFAF has higher annual earnings (EBITDA): -1.68M vs. SOLTF (-3.81B). SOLTF has more cash in the bank: 51B vs. BSFAF (1.37M). BSFAF has less debt than SOLTF: BSFAF (118K) vs SOLTF (71.1B). SOLTF has higher revenues than BSFAF: SOLTF (23.3B) vs BSFAF (67.2K).
BSFAFSOLTFBSFAF / SOLTF
Capitalization3.33M575M1%
EBITDA-1.68M-3.81B0%
Gain YTD-12.5001.015-1,231%
P/E RatioN/AN/A-
Revenue67.2K23.3B0%
Total Cash1.37M51B0%
Total Debt118K71.1B0%
FUNDAMENTALS RATINGS
SOLTF: Fundamental Ratings
SOLTF
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BSFAFSOLTF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
41%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
49%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
7%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
2%
Bearish Trend 2 days ago
53%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
44%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
42%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYPFX9.080.03
+0.33%
Royce Small-Cap Fund Svc
PNRAX56.73N/A
N/A
Putnam Research A
UPUPX11.41N/A
N/A
Upright Growth
AMVGX16.20N/A
N/A
American Century Mid Cap Value R5
TNRAX20.03N/A
N/A
1290 Avantis U.S. Large Cap Growth A

BSFAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSFAF has been closely correlated with BIESF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSFAF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSFAF
1D Price
Change %
BSFAF100%
N/A
BIESF - BSFAF
82%
Closely correlated
N/A
SOLTF - BSFAF
29%
Poorly correlated
+0.32%
YECO - BSFAF
24%
Poorly correlated
N/A
APLM - BSFAF
21%
Poorly correlated
+2.97%
CERO - BSFAF
21%
Poorly correlated
+1.18%
More